McMurray JJ. EMPEROR-Reduced: Confirming sodium-glucose cotransporter 2 (SGLT2) inhibitors as an essential treatment for patients with heart failure with reduced ejection fraction. Eur J Heart Fail 2020 Sep 18. doi: 10.1002/ejhf.2006.
PMID: 32946169